Efficacy and tolerability of chemotherapy with modified dose-dense TCF regimen (TCF-dd) in locally advanced or metastatic gastric cancer: final results of a phase II trial
Conclusions
The TCF-dd regimen in locally advanced or MGC is confirmed to be feasible and very active and needs to be further tested in randomized studies.
Source: Gastric Cancer - Category: Gastroenterology Source Type: research
More News: Anemia | Cancer | Cancer & Oncology | Chemotherapy | Docetaxel | Gastric (Stomach) Cancer | Gastroenterology | Study | Taxotere | Thrombocytopenia | Toxicology